these were not completed in peer-reviewed form, and a Phase I safety study has been mentioned in the literature but its results were never published
CuHeal excludes diabetes, peripheral vascular disease, immunodeficiency, pregnancy, breastfeeding, recent immunosuppressant or cytotoxic medication use, and several wound-healing risk factors [7]
Combining IV therapy with occasional injections may help manage long term costs for some individuals
In assays of neurotrophic activity, Dihexa has been found to be seven orders of magnitude more potent than brain-derived neurotrophic factor (BDNF), with demonstrated improvements in cognitive function in animal models of Alzheimers disease-like impairment
Increased oxidative deoxyribonucleic acid damage in the spermatozoa of infertile male patients
In a 2023 study , researchers found no connection with low B12 levels and erectile dysfunction, contrary to the general trend in the medical literature